MINNEAPOLIS, April 01, 2016 -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 15th Annual Needham Healthcare Conference in New York on Tuesday, April 12th at 5:00pm (EDT).
Phil Nalbone, VP of Corporate Development of Vascular Solutions, will deliver the Company’s presentation. To hear the live audio webcast of the Vascular Solutions’ presentation, go to the investor relations page of the Company’s web site www.vasc.com and click on the “Investor Conferences” icon a few minutes prior to start time to download any necessary software.
About Needham Company, LLC
Needham & Company, LLC, a wholly owned subsidiary of The Needham Group, Inc., is a privately held, full-service investment bank that has focused exclusively on growth companies since its founding 31 years ago. It provides its clients with the resources to achieve their financing and strategic objectives. The Firm has capital raising expertise in IPOs, follow-on public equity offerings, confidentially marketed equity offerings, private placements, and in mergers and acquisitions, and corporate and venture services (including share repurchases). In addition to investment banking, Needham & Company LLC’s activities include institutional sales and trading, and asset management. To serve its institutional clients, Needham & Company, LLC produces comprehensive equity research on more than 325 companies in communications and enterprise infrastructure; healthcare; industrial technology; Internet, entertainment and consumer; semiconductors and semiconductor equipment; and software and services, and makes a market in over 600 stocks. The Firm is headquartered in New York City with offices in Boston, MA; Chicago, IL; Menlo Park, CA; and San Francisco, CA. Needham & Company, LLC is a member of FINRA & SIPC. For more information, please visit www.needhamco.com.
About Vascular Solutions
Vascular Solutions, Inc. is an innovative medical device company that focuses on developing unique clinical solutions for coronary and peripheral vascular procedures. The company’s product line consists of more than 100 products and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists, and vein specialists through its direct U.S. sales force and international independent distributor network.
Contact: Phil Nalbone, VP Vascular Solutions, Inc. (763) 656-4300


Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO
CATL Stock Hits Record High After Q1 2025 Earnings Surge
Anthropic Nears $800 Billion Valuation as Investor Confidence Surges
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs 



